Cargando…

COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia

Hydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus. These three cases of COVID-19 pneumonia of varying severities occurred in the setting of chronic hydroxychloroquine use. These cases argue against...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Awan K., Purdy, Adam G., Ender, Peter T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582078/
https://www.ncbi.nlm.nih.gov/pubmed/33123391
http://dx.doi.org/10.1155/2020/8822753
_version_ 1783599112896118784
author Rahman, Awan K.
Purdy, Adam G.
Ender, Peter T.
author_facet Rahman, Awan K.
Purdy, Adam G.
Ender, Peter T.
author_sort Rahman, Awan K.
collection PubMed
description Hydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus. These three cases of COVID-19 pneumonia of varying severities occurred in the setting of chronic hydroxychloroquine use. These cases argue against the use of hydroxychloroquine as a preventative or therapeutic option for COVID-19 pneumonia.
format Online
Article
Text
id pubmed-7582078
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-75820782020-10-28 COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia Rahman, Awan K. Purdy, Adam G. Ender, Peter T. Case Rep Infect Dis Case Report Hydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus. These three cases of COVID-19 pneumonia of varying severities occurred in the setting of chronic hydroxychloroquine use. These cases argue against the use of hydroxychloroquine as a preventative or therapeutic option for COVID-19 pneumonia. Hindawi 2020-10-22 /pmc/articles/PMC7582078/ /pubmed/33123391 http://dx.doi.org/10.1155/2020/8822753 Text en Copyright © 2020 Awan K. Rahman et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Rahman, Awan K.
Purdy, Adam G.
Ender, Peter T.
COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
title COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
title_full COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
title_fullStr COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
title_full_unstemmed COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
title_short COVID-19 Pneumonia in Patients on Chronic Hydroxychloroquine Therapy: Three Cases of COVID-19 Pneumonia
title_sort covid-19 pneumonia in patients on chronic hydroxychloroquine therapy: three cases of covid-19 pneumonia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582078/
https://www.ncbi.nlm.nih.gov/pubmed/33123391
http://dx.doi.org/10.1155/2020/8822753
work_keys_str_mv AT rahmanawank covid19pneumoniainpatientsonchronichydroxychloroquinetherapythreecasesofcovid19pneumonia
AT purdyadamg covid19pneumoniainpatientsonchronichydroxychloroquinetherapythreecasesofcovid19pneumonia
AT enderpetert covid19pneumoniainpatientsonchronichydroxychloroquinetherapythreecasesofcovid19pneumonia